title: Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.
abstract: BACKGROUND
  Although liver transplantation has become a standard therapy for diseases such as fulminant hepatitis and cirrhosis, the lack of donor organs remains a major problem. One solution is the development of transplantable hepatocytes. The metabolic characteristics as well as function and adaptation of hepatocytes (R-EES-hep cell) derived from rat early embryonic stem cells were examined after transplantation into rats with surgically induced liver failure.
  
  
  METHODS
  Rat hepatocyte cell lines were established from early embryonic stem cells cultured in the presence of embryotrophic factors by colony cloning methods. The cell lines were established from two cell embryos taken from spontaneous dwarf rats using the novel method of Ishiwata et al. Morphologic differentiation as well as albumin and bilirubin production were observed by immunostaining. R-EES-hep cells were transplanted into the spleens of 90% hepatectomized, surgically induced liver failure rats to analyze survival rates.
  
  
  RESULTS
  When cultured in type I collagen gel the cells formed cordlike structures resembling the liver. Both albumin and bilirubin production were observed when transplanted; the spleen was converted into a liver-like structure with prolonged survival of the 90% hepatectomized rats for up to 3 months up to the time of killing.
  
  
  CONCLUSIONS
  R-EES-hep cells showed many of the distinctive metabolic characteristics of the liver. These cells may be efficient for further research and application for hepatic cell transplantation to treat liver insufficiency patients and as biologic artificial organs.
authors.affiliation: Department of Surgery, Jikei University School of Medicine, Tokyo, Japan. tabei@jikei.ac.jp
authors.forename: I
authors.initials: I
authors.lastname: Tabei
authors.forename: H
authors.initials: H
authors.lastname: Hashimoto
authors.forename: I
authors.initials: I
authors.lastname: Ishiwata
authors.forename: T
authors.initials: T
authors.lastname: Tachibana
authors.forename: M
authors.initials: M
authors.lastname: Akahori
authors.forename: S
authors.initials: S
authors.lastname: Ohi
authors.forename: H
authors.initials: H
authors.lastname: Kubo
authors.forename: K
authors.initials: K
authors.lastname: Satou
authors.forename: Y
authors.initials: Y
authors.lastname: Yamazaki
authors.forename: K
authors.initials: K
authors.lastname: Yanaga
authors.forename: H
authors.initials: H
authors.lastname: Ishikawa
mesh_terms: D000818:Animals; D002460:Cell Line; D006498:Hepatectomy; D022781:Hepatocytes / Q000166:cytology* / Q000378:metabolism / Q000637:transplantation*; D008099:Liver / Q000601:surgery; D008107:Liver Diseases; D017093:Liver Failure / Q000209:etiology / Q000628:therapy*; D019164:Liver, Artificial; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D033581:Stem Cell Transplantation; D013234:Stem Cells